When a patient with obesity reports a new symptom, many physicians are quick to focus on the excess weight without exploring alternative reasons. Wrong approach, experts said.

The results bring Eli Lilly’s pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...